Journal of Chinese Pharmaceutical Sciences ›› 2016, Vol. 25 ›› Issue (4): 318-320.
• Others • Previous Articles
http://www.fda.gov#br#
Received:
Revised:
Online:
Published:
Abstract:
The U.S. Food and Drug Administration today approved Inflectra (infliximab-dyyb) for multiple indications. Inflectra is administered by intravenous infusion. This is the second biosimilar approved by the FDA.
Supporting:
http://www.fda.gov. Information from US FDA[J]. Journal of Chinese Pharmaceutical Sciences, 2016, 25(4): 318-320.
0 / / Recommend
Add to citation manager EndNote|Ris|BibTeX
URL: http://jcps.bjmu.edu.cn/EN/
http://jcps.bjmu.edu.cn/EN/Y2016/V25/I4/318
>
>